Weekly Wrap: Johnson & Johnson Not Best Value in Healthcare

First-quarter earnings for the healthcare firm reinforce that it is not the best buy. Plus, slow growth for IBM, and Netflix is overvalued.

For all Morningstar videos: http://www.morningstar.com/cover/videocenter.aspx



Continue reading at Morningstar (via YouTube) →